CASEY MAYER: Open Payments
NPI 1023461308 · MILFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 23 payments from 10 companies in 2025. Trend: 2023 $667 · 2024 $161 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $189 |
| Lilly USA, LLC | 2 | $147 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $38 |
| LEO Pharma Inc. | 2 | $33 |
| GENZYME CORPORATION | 1 | $31 |
| UCB, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, LITFULO, TALTZ, ILUMYA, ADBRY.
Industry payments across DE — which companies pay providers there.
